Sign in
CompletedNo phase

TMS + Exposure Therapy for Pediatric OCD

Key facts

Who runs it
Bradley Hospital
Where
Minneapolis and Riverside, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
59 people enrolled
Started
20 Mar 2024
Ended
31 Jul 2026
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Transcranial Magnetic Stimulation: intermittent theta burst to dorsolateral prefrontal cortex
  • Exposure with Response Prevention
  • Transcranial Magnetic Stimulation: Sham
  • Transcranial Magnetic Stimulation: continuous theta burst to pre supplementary motor area
Record updated
19 October 2026

Who can take part

Age
12 years to 21 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Between the ages of 12 and 21 years
  • Presence of OCD, as indicated by a score of > 16 on the Children's Yale-Brown Obsessive Compulsive Scale, indicating moderate or greater OCD symptoms
  • Presence of motor compulsions on CY-BOCS compulsion checklist
  • English fluency to ensure comprehension of informed consent and study measures and instructions

Who cannot take part

  • Concurrent psychotherapy of any kind for OCD
  • Concurrent TMS or receipt of any TMS experimental or clinical treatment less than 3 months prior to enrollment
  • Taking a medication deemed to pose high seizurogenic potential per physician review
  • Taking a medication that has not reached stability criterion (same medication and dose for 6 weeks with no planned changes over the study period)
  • Has a personal history, or a family history in a first-born relative, of any medical or psychiatric disorder, disease, condition, injury, symptoms or circumstance that, in the opinion of the principal investigator, may: (1) impact the risk profile of TMS; (2) reduce the subject's ability to fulfill the study requirements as per protocol; or (3) adversely impact the integrity of the data or the validity of the study results." Some examples include: epilepsy or seizure disorder(s), bipolar disorder or any psychiatric disorder associated with a risk of mania, intracranial pathology, traumatic brain injury, brain tumor, stroke, implanted medical devices or metallic objects in the head, or moderate-severe heart disease
  • History of, or risk factors for, neurocardiogenic syncope (history of syncope/ presyncope related to noxious stimuli, anxiety, micturation, or posture)
  • Decline to provide informed consent
  • Pregnant according to the medical history or a urine pregnancy test; and menstruating females who are heterosexually active and not using a highly effective form of contraception (tubal ligation, FDA-approved hormonal contraceptive, or an IUD)
  • Inability to undergo MRI
  • Left handedness
  • Is deemed to be at imminent risk of suicide according to the Ask Suicide-Screening Questions (ASQ) (i.e. answers YES to ≥ one (1) of the four screening questions) and/or in the medical opinion of the investigator

Where in United States

  • University of MinnesotaMinneapolis, United States
  • Emma Pendleton Bradley HospitalRiverside, United States

About the trial

What the trial wants to find out

The goal of this clinical trial is to compare different forms of transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in youth and young adults with Obsessive-Compulsive Disorder (OCD). Researchers will compare three groups: ERP with one of two different active ("real") forms of TMS vs. ERP with sham ("fake") TMS. The main questions this study aims to answer are: 1) whether TMS normalizes functioning in brain circuits that contribute to compulsive behavior, and 2) whether TMS reduces compulsions during ERP. Participants will:

Read full original descriptionShow less

* Complete clinical interviews, questionnaires, and computerized tasks * Complete two MRIs (brain scans) * Receive daily TMS followed by ERP for two weeks (10 sessions)

The 3 groups in the trial

  • ERP+iTBSTreatment being tested

    Participants will receive two weeks (10 sessions) of intermittent theta burst stimulation (iTBS; a form of TMS) targeting the dorsolateral prefrontal cortex (dlPFC), followed immediately by Exposure Plus Response Prevention (ERP).

    Treatment: Transcranial Magnetic Stimulation: intermittent theta burst to dorsolateral prefrontal cortex and Exposure with Response Prevention

  • ERP+cTBSTreatment being tested

    Participants will receive two weeks (10 sessions) of continuous theta burst stimulation (cTBS; a form of TMS) targeting the presupplementary motor area (pSMA), followed immediately by Exposure Plus Response Prevention (ERP).

    Treatment: Exposure with Response Prevention and Transcranial Magnetic Stimulation: continuous theta burst to pre supplementary motor area

  • ERP+ShamExisting treatment, for comparison

    Participants will receive two weeks (10 sessions) of sham ("fake") TMS, followed immediately by Exposure Plus Response Prevention (ERP).

    Treatment: Exposure with Response Prevention and Transcranial Magnetic Stimulation: Sham

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Transcranial Magnetic Stimulation to Augment Exposure and Response Prevention for Pediatric OCD
Record updated
19 October 2026